Mark was Chief Operating Officer and General Counsel at Kinnate Biopharma, and Senior Vice President and General Counsel at Audentes Therapeutics. Mark Meltz joined Lyell Immunopharma in 2025.
Mark Meltz is currently
Create your alert
to follow the career of Mark Meltz.
Mark Meltz has a Juriste Doctor, Law Degree from Boston College Law School and a Bachelor of Arts in Psychology from Yale University.
They have also studied at Yale University :
Find more alumni from Yale University
Do you need to know more about Mark Meltz? More results.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.